 
                                Ruella Lab
@ruellalab
We focus on mechanisms of relapse after CAR-T therapy. Our goal is to design innovative combined IMT for relapsing/refractory Leukemia & Lymphoma. @MarcoRuella
ID: 1210594006641651715
https://www.med.upenn.edu/cci/ruellalab/ 27-12-2019 16:12:27
5 Tweet
144 Takipçi
11 Takip Edilen
 
         
        This review by guru puneeth, Marco Ruella et al. Ruella Lab Penn Medicine examines how single-cell RNA sequencing has transformed the understanding of basic #cancer and immune biology in the context of cancer #immunotherapy. bit.ly/3mslYtT #JEMCancerFocus
 
                        
                    
                    
                    
                 
        Our latest review on single-cell RNAseq in immunotherapy is out in Journal of Experimental Medicine! Thanks for this Herculean endeavour to guru puneeth and Ruella Lab Penn Medicine @Penn_IFI
 
        Our letter to the NEJM reporting the five-year outcomes of CART19 (CTL019, now called tisagenlecleucel) in lymphoma patients is out! Thanks to Drs. Schuster, Chong and Penn Medicine Penn Medicine - Abramson Cancer Center @Penn_IFI Carl June Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 nejm.org/doi/full/10.10…
 
        .guru puneeth et al. Ruella Lab discuss the current landscape of single-cell transcriptomics for cancer #immunotherapy. bit.ly/3mslYtT From our Cancer Immunotherapy collection to accompany #SITC21 👉 bit.ly/3H5wvXl
 
                        
                    
                    
                    
                